The effects of fampridine on MS-related fatigue: a systematic review
BackgroundSlow-release 4-aminopyridine (fampridine) has been shown to improve walking function in people with multiple sclerosis (MS). Its effect on other MS symptoms, such as fatigue, remains controversial. We performed this systematic review to summarize the evidence of the effect of fampridine on...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2026-01-01
|
| Sarja: | Frontiers in Neurology |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1720316/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|